The World Health Organization said more than 170 countries had joined its global plan for the equitable distribution of vaccines worldwide, but warned that a career to expand vaccines can lead to public protection concerns.
Trials of a vaccine in Britain were suspended this month following a disease in a participant, while Russia rejected the complaint from Western experts about the early use of its candidate vaccine.
“We are already facing demanding situations with the acceptance of vaccines for many vaccines shown,” said WHO Chief Tedros Adhanom Ghebreyesus, in pre-recorded commentary, when talking about a preference for expanding vaccines.
“We threaten to have an effective vaccine opposed to Covid-19 that other people reject because of the belief that it is dangerous. “
Prior to Friday’s deadline for access to its COVAX vaccine facility, Tedros said the more than 170 countries that had joined “are guaranteed the world’s largest candidate vaccine portfolio. “
WHO had stated in the past that 92 low-income countries were applying for assistance through the programme and some 80 high-income countries had expressed interest, although some had not yet verified their target before the deadline.
WHO and the GAVI vaccine alliance lead the COVAX programme, which aims to purchase and distribute 2 billion doses of vaccines approved by the end of 2021.
But some countries that have secured their own materials through bilateral agreements, adding to the United States, have said they will not subscribe to COVAX.
“The first vaccine to be approved may not be the best,” Tedros said in a webinar organized through the National University of Singapore. “The more shots to the bow, the greater the chances of getting a very effective vaccine. “
Do you have any confidential information? We want to hear from you.
Sign up for loose newsletters and get more CNBC in your inbox
Get it in your inbox and more information about our services.
© 2020 CNBC LLC. All rights are reserved. An NBCUniversal department
Knowledge is a real-time snapshot: data is delayed for at least 15 minutes, monetary and global industry news, inventory quotes, and market knowledge and analysis.
Data also by